WallStreetZenWallStreetZen

NASDAQ: RLMD
Relmada Therapeutics Inc Stock Ownership - Who owns Relmada Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Relmada Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Maged ShenoudaChief Financial Officer2025-12-1511,665$4.12
$48.06kBuy
Sergio TraversaChief Executive Officer2025-12-1527,500$4.12
$113.30kBuy
Maged ShenoudaChief Financial Officer2025-11-05500,000$2.20
$1.10MBuy
Chuck EnceCAO and COO2025-11-05136,000$2.20
$299.20kBuy
Paul Edward KellyChief Operating Officer2025-11-0590,000$2.20
$198.00kBuy
Sergio TraversaChief Executive Officer2025-11-05272,500$2.20
$599.50kBuy
Sergio TraversaChief Executive Officer2025-08-2855,976$0.74
$41.42kBuy
Sergio TraversaChief Executive Officer2025-08-27129,455$0.67
$86.73kBuy
Sergio TraversaChief Executive Officer2025-08-2680,545$0.62
$49.94kBuy

1 of 1

RLMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLMD insiders and whales buy or sell their stock.

RLMD Shareholders

What type of owners hold Relmada Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC10.55%11,063,862$69.81MInstitution
Squadron Capital Management LLC8.08%8,474,571$53.47MInstitution
Spruce Street Capital LP5.97%6,262,114$39.51MInstitution
Venrock Adviser LLC4.62%4,843,380$30.56MInstitution
Adage Capital Partners GP LLC4.54%4,763,158$30.06MInstitution
Orbimed Advisors LLC4.50%4,715,864$29.76MInstitution
Marshall Wace LLP4.27%4,481,606$28.28MInstitution
Millennium Management LLC3.73%3,907,265$24.65MInstitution
Vanguard Capital Management LLC2.93%3,076,570$19.41MInstitution
Ra Capital Management LP2.81%2,947,369$18.60MInstitution

1 of 3

RLMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLMD79.76%3.37%Net Buying
CADL59.27%24.06%Net Buying
KZIA0.03%0.39%
BBOT62.76%37.24%Net BuyingNet Selling
ZVRA69.89%21.79%Net SellingNet Buying
View Top Biotech Stocks

Relmada Therapeutics Stock Ownership FAQ

Who owns Relmada Therapeutics?

Relmada Therapeutics (NASDAQ: RLMD) is owned by 79.76% institutional shareholders, 3.37% Relmada Therapeutics insiders, and 16.87% retail investors. Sergio Traversa is the largest individual Relmada Therapeutics shareholder, owning 1.30M shares representing 1.24% of the company. Sergio Traversa's Relmada Therapeutics shares are currently valued at $7.74M.

If you're new to stock investing, here's how to buy Relmada Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.